Europe · General news · 20minutos

Un nuevo fármaco reduce un 32% el riesgo de muerte en cáncer de endometrio avanzado o recurrente

Published by 20minutos · Spain 2 h ago

El ensayo con el fármarco ha contado con la participación de 242 centros hospitalarios de 31 países.

Read the full article on 20minutos Sign in to save

MarketNews shows the headline and summary published by the outlet. The full article is on the publisher's website. (www.20minutos.es)

Also worth reading

The Independent

Trump calls Lula's election win in Brazil 'rigged' after his ally refused to concede

Terrifying secret clauses inside Anthropic's own IPO filings reveal how AI tech may destroy the world

Thousands fly home to have say in tight Israeli election

Evening Standard

London set for 10 days of dry weather after storms wreak havoc

UK bride gets 'potentially deadly' wedding cake - then maker refuses refund

Light-fingered woman ‘caught stealing table lamps from pub’